126 related articles for article (PubMed ID: 26063221)
1. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-181b-5p Facilitates Thyroid Cancer Growth via Targeting Programmed Cell Death 4.
Geng X; Li Y; Sun Y; Cao L; Song Z
Mol Biotechnol; 2024 May; 66(5):1154-1164. PubMed ID: 38253901
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-3653-3p inhibited papillary thyroid carcinoma progression by regulating CRIPTO-1.
Bai X; Xu Y; Liu Y
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):272-276. PubMed ID: 38279419
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression.
Sun Y; Shi T; Ma Y; Qin H; Li K
Cell Cycle; 2020 Apr; 19(7):787-800. PubMed ID: 32075502
[TBL] [Abstract][Full Text] [Related]
5. miRNA-106a directly targeting RARB associates with the expression of Na(+)/I(-) symporter in thyroid cancer by regulating MAPK signaling pathway.
Shen CT; Qiu ZL; Song HJ; Wei WJ; Luo QY
J Exp Clin Cancer Res; 2016 Jun; 35(1):101. PubMed ID: 27342319
[TBL] [Abstract][Full Text] [Related]
6. circFAT1(e2) Promotes Papillary Thyroid Cancer Proliferation, Migration, and Invasion via the miRNA-873/ZEB1 Axis.
Liu J; Li H; Wei C; Ding J; Lu J; Pan G; Mao A
Comput Math Methods Med; 2020; 2020():1459368. PubMed ID: 33133224
[TBL] [Abstract][Full Text] [Related]
7. LncRNA HAGLROS contribute to papillary thyroid cancer progression by modulating miR-206/HMGA2 expression.
Zeng Z; Tang S; Chen L; Hou H; Liu Y; Li J
Aging (Albany NY); 2023 Dec; 15(24):14930-14944. PubMed ID: 38112616
[TBL] [Abstract][Full Text] [Related]
8. miR-208a-3p suppresses cell apoptosis by targeting PDCD4 in gastric cancer.
Yin K; Liu M; Zhang M; Wang F; Fen M; Liu Z; Yuan Y; Gao S; Yang L; Zhang W; Zhang J; Guo B; Xu J; Liang H; Chen X; Guan W
Oncotarget; 2016 Oct; 7(41):67321-67332. PubMed ID: 27634902
[TBL] [Abstract][Full Text] [Related]
9. miR-23a promotes IKKα expression but suppresses ST7L expression to contribute to the malignancy of epithelial ovarian cancer cells.
Yang Z; Wang XL; Bai R; Liu WY; Li X; Liu M; Tang H
Br J Cancer; 2016 Sep; 115(6):731-40. PubMed ID: 27537390
[TBL] [Abstract][Full Text] [Related]
10. miR-23a/b promote tumor growth and suppress apoptosis by targeting PDCD4 in gastric cancer.
Hu X; Wang Y; Liang H; Fan Q; Zhu R; Cui J; Zhang W; Zen K; Zhang CY; Hou D; Zhou Z; Chen X
Cell Death Dis; 2017 Oct; 8(10):e3059. PubMed ID: 28981115
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of ESM1 by shRNA-mediated knockdown of its expression in papillary thyroid cancer cells.
Xie L; He L; Zhang W; Wang H
PLoS One; 2024; 19(4):e0298631. PubMed ID: 38626010
[TBL] [Abstract][Full Text] [Related]
12. MiR-204-5p-targeted AP1S2 is necessary for papillary thyroid carcinoma.
Gu Y; Zhang X; Li Y; Shi J; Cui H; Ren Y; Liu S; Qiao Y; Cheng Y; Liu Y
Mol Cell Endocrinol; 2023 Aug; 574():111993. PubMed ID: 37328093
[TBL] [Abstract][Full Text] [Related]
13. CircSEMA6A upregulates PRRG4 by targeting MiR-520h and recruiting ELAVL1 to affect cell invasion and migration in papillary thyroid carcinoma.
Liu Y; Xin Y; Shang X; Tian Z; Xue G
Arch Endocrinol Metab; 2024 Feb; 68():e210541. PubMed ID: 38394156
[TBL] [Abstract][Full Text] [Related]
14. PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance.
Zennami K; Choi SM; Liao R; Li Y; Dinalankara W; Marchionni L; Rafiqi FH; Kurozumi A; Hatano K; Lupold SE
Mol Cancer Res; 2019 Feb; 17(2):618-627. PubMed ID: 30518628
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-150 inhibitors enhance cell apoptosis of melanoma by targeting PDCD4.
Wan J; Yang J; Huang Y; Deng L
Oncol Lett; 2018 Feb; 15(2):1475-1482. PubMed ID: 29434838
[TBL] [Abstract][Full Text] [Related]
16. Translocated HMGB3 is involved in papillary thyroid cancer progression by activating cytoplasmic TLR3 and transmembrane TREM1.
Zhao Y; Lv HJ; Deng XY; Chen P; Garstka MA; Shi BY; Fu J
Cell Cycle; 2023; 22(23-24):2584-2601. PubMed ID: 38197217
[TBL] [Abstract][Full Text] [Related]
17. miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer.
Xiong Y; Kotian S; Zeiger MA; Zhang L; Kebebew E
PLoS One; 2015; 10(8):e0130496. PubMed ID: 26244545
[TBL] [Abstract][Full Text] [Related]
18. Testosterone promotes the migration, invasion and EMT process of papillary thyroid carcinoma by up-regulating Tnnt1.
Jiang C; Xu F; Yi D; Jiang B; Wang R; Wu L; Ding H; Qin J; Lee Y; Sang J; Shi X; Su L
J Endocrinol Invest; 2024 Jan; 47(1):149-166. PubMed ID: 37477865
[TBL] [Abstract][Full Text] [Related]
19. PIWIL1 Promotes Malignant Progression of Papillary Thyroid Carcinoma by Inducing EVA1A Expression.
Liu L; Wu F; Zhang X; Li X
Curr Cancer Drug Targets; 2024; 24(2):192-203. PubMed ID: 37403394
[TBL] [Abstract][Full Text] [Related]
20. Non-thermal atmospheric pressure plasma inhibits thyroid papillary cancer cell invasion via cytoskeletal modulation, altered MMP-2/-9/uPA activity.
Chang JW; Kang SU; Shin YS; Kim KI; Seo SJ; Yang SS; Lee JS; Moon E; Lee K; Kim CH
PLoS One; 2014; 9(3):e92198. PubMed ID: 24667444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
